News
-
-
PRESS RELEASE
Mutares increases Holding net income by 32% to just under EUR 70 million in the first half of 2025 – More exit activity expected for the rest of the year
Mutares Holding reports 32% increase in net income to just under EUR 70 million in the first half of 2025. Group revenue rises by 19% to EUR 3,106.3 million. More exit activity expected, confirming forecast for fiscal year 2025 -
-
-
-
PRESS RELEASE
Sonova expands Infinio range and enters new market segment with Phonak’s smallest and first rechargeable in-the-ear hearing aid
Sonova expands Infinio range with Phonak's smallest rechargeable in-the-ear hearing aid, Phonak Virto R Infinio. The launch marks an important step in entering the market segment -
-
-
PRESS RELEASE
Newron begins enrollment in pivotal Phase III ENIGMA-TRS program with evenamide as add-on therapy in patients with treatment-resistant schizophrenia (TRS)
Newron Pharmaceuticals initiates Phase III ENIGMA-TRS program with evenamide as add-on therapy for treatment-resistant schizophrenia patients, targeting TRS population -
